BAL PHARMA
Back to Balance Sheet
|
BAL PHARMA Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹113 Cr | ₹100 Cr | ₹86 Cr | ₹83 Cr | ₹76 Cr |
What is the latest Total Non-Current Assets ratio of BAL PHARMA ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2026 | ₹113 Cr |
| Mar2025 | ₹100 Cr |
| Mar2024 | ₹86 Cr |
| Mar2023 | ₹83 Cr |
| Mar2022 | ₹76 Cr |
How is Total Non-Current Assets of BAL PHARMA Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹113 Cr | 12.04 | |
| Mar2025 | ₹100 Cr | 17.19 | |
| Mar2024 | ₹86 Cr | 3.41 | |
| Mar2023 | ₹83 Cr | 9.07 | |
| Mar2022 | ₹76 Cr | - | |
Compare Total Non-Current Assets of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹151.1 Cr | 11.3% | 4.5% | 4.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,339.0 Cr | -2.7% | -3.7% | 20.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹254,068.0 Cr | 3.7% | 15.7% | 51% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,767.0 Cr | -0.8% | 1% | 36.2% | Stock Analytics | |
| CIPLA | ₹111,804.0 Cr | -2.1% | -5.2% | -11.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,113.4 Cr | -0.8% | -0.5% | -9.3% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | 11.3% |
4.5% |
4.7% |
| SENSEX | -1.8% |
-3.7% |
-5.7% |
You may also like the below Video Courses